ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
NBrown Group PLC (PK)

NBrown Group PLC (PK) (NBRNF)

0.5417
0.00
(0.00%)
마감 27 9월 5:00AM

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

주요 통계 및 세부정보

가격
0.5417
매수가
0.2855
매도가
0.3655
거래량
-
0.00 일간 변동폭 0.00
0.17 52주 범위 0.5417
전일 종가
0.5417
개장가
-
최근 거래 시간
마지막 거래 시간
평균 볼륨(3m)
-
재정 규모
-
VWAP
-

NBRNF 최신 뉴스

No news to show yet.
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1000.54170.54170.541700CS
4000.54170.54170.541700CS
12000.54170.54170.541700CS
26000.54170.54170.541700CS
520.3717218.6470588240.170.54170.1747400.17CS
156000.54170.54170.1724080.22817769CS
260-1.1383-67.7559523811.681.680.1716250.28610697CS

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
AABVFAberdeen International Inc (PK)
US$ 0.02914
(0.00%)
0
AABKFAareal Bank AG (PK)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.0387
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0
AABVFAberdeen International Inc (PK)
US$ 0.02914
(0.00%)
0
AABKFAareal Bank AG (PK)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.0387
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0
SMMESmartMetric Inc (PK)
US$ 0.00015
(0.00%)
5M
HCMCHealthier Choices Management Corporation (PK)
US$ 0.0001
(0.00%)
3M
ACGBYAgricultural Bank of China (PK)
US$ 13.08
(0.00%)
2M
CAOVYChina Overseas Land and Investment Ltd (PK)
US$ 9.53
(0.00%)
1.56M
CICHFChina Construction Bank (PK)
US$ 0.794425
(0.00%)
843.43k
Risk Risk 3 분 전
This is awesome. Thanks TJ. Need a lot of patience.
AFFU
nidan7500 nidan7500 3 분 전
georgejjiUS FDA approves Bristol Myers' schizophrenia drug

FDA approval for new type of schizophrenia treatment

ristol prices drug at $1,850 a month

https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-bristol-myers-schizophrenia-dr
AVXL
RobotDroid RobotDroid 4 분 전
Another wrong opinion. Too funny how the cult looks at other companies data and thinks it applies to nwbo. It doesn't, no other compnay has the worst, inept mute mismanagement clown show in history.
NWBO
Risk Risk 4 분 전
TJ that’s better dream :)) OS dream big :))
AFFU
Wingsjr Wingsjr 5 분 전
Thx, brother. 👍
FNMA
Golden Cross Golden Cross 5 분 전
$XXII New Customer for 22nd Century's Internally Owned Moonlight Brand Could Increase Factory Volumes by More Than 30% When Fully Scaled, Improve Gross Profit Profile
https://www.newsfilecorp.com/release/224193/22nd-Century-Announces-New-Branded-Products-Order-with-Customer-for-Southeast-Asi
XXII
GetSeriousOK GetSeriousOK 6 분 전
Call her then.

And don't accept "we'll release a PR when it's appropriate" for an answer.

Personally, I wouldn't believe anything she told you over the phone, but that's just my experience with biotech CEO phone calls. Whatever she says, tell her "Put that in writing.
BIEL
Golden Cross Golden Cross 6 분 전
$XXII New Customer for 22nd Century's Internally Owned Moonlight Brand Could Increase Factory Volumes by More Than 30% When Fully Scaled, Improve Gross Profit Profile
https://www.newsfilecorp.com/release/224193/22nd-Century-Announces-New-Branded-Products-Order-with-Customer-for-Southeast-Asi
XXII
weedtrader420 weedtrader420 6 분 전
XRP✊😎 Lynyrd Skynyrd SIMPLE MAN $1 TARGET
XRPUSD
MFranny MFranny 6 분 전
That's where, at the very least, Steven Walker should have been present. But he wasn't...
SHMP
GetSeriousOK GetSeriousOK 7 분 전
Sorry, the patents expired due to non-payment of maintenance fees.

"Extended to 2029" refers to the Patent Term Restoration (PTR) extension. IF Whelan had paid the maintenance fees, the patents would be active until 2029. Without that extension they would have expired in 2023, twenty
BIEL
manibiotech manibiotech 7 분 전
In that case they will have to take personal responsibility and be held accountable . Current strategy transfers 100% of responsibility and blame on someone else . So what’s the incentive to change ?
NWBO
zj3001 zj3001 7 분 전
$RNAZ everyone so focused on a price per share, but no one ever talks about market cap. Imagine Transcode getting a $50-200m upfront payment to partner with Big Pharma. What do you think that makes the value of the company?

What if they get fda fast track approval?

It
RNAZ
Alexulf Alexulf 8 분 전
We continue the climb up!

Strong news do the trick :-)

https://aitx.ai/
AITX
MetaMonster MetaMonster 8 분 전
Ceo Mark White is in rehab for drug addiction
FOXO
FeMike FeMike 8 분 전
That's just a guess, and probably wrong.
You realize you are an absolute moron, right? 3 months ago after the ASM, when I said we hadn't gotten an RFI yet and were still in phase 1, you told me that was "100% not true". When i asked you to clarify, you said:
We are not in phase 1. Th
ASM
James56 James56 8 분 전
Soon.
MDCE
2020trader 2020trader 8 분 전
that would be a wasted call...lol
CLNV
1vman 1vman 8 분 전
*****Wowzah🟥🟥🟥🟥 Power2theGMEshorters/brilliant, interest has faded big time here

ENOUGH SAID
GME
arachnodude arachnodude 9 분 전
Consider demand influences the rate at which they produce, but the capacity reflects what the facility is capable of producing under optimal conditions, regardless of how much is currently being ordered or sold.
KBLB
kid70 kid70 9 분 전
Hopefully, we can beat yesterday volume. Lol
UBQU
Deano361 Deano361 9 분 전
Now from 100 to 500m?
FUNR